解锁LSD1在瘤免疫中的双重作用:先天性和适应性途径
Yu Zhang1,2, Ningjie Guo1, Haoyi Zhu1
1State Key Laboratory of Esophageal Cancer Prevention & Treatment; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China; Key Laboratory of Henan Province for Drug Quality and Evaluation, Henan Province; School of Pharmaceutical Sciences; Academy of Medical Sciences; Tianjian Laboratory of Advanced Biomedical Sciences; Zhengzhou University, Zhengzhou, Henan 450001, China.
素脱甲基酶LSD1 (素特异性脱甲基酶1) 通过调节先天性和适应性免疫反应,影响瘤免疫力. 抑制LSD1显示出增强癌症免疫疗法的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 素基因特异性去甲基酶1 (LSD1) 经常在各种癌症中过度表达.
- LSD1在调节免疫细胞功能,免疫检查点和免疫调节器表达方面发挥着至关重要的作用.
- 了解LSD1对先天性和适应性免疫的影响对于癌症治疗至关重要.
研究的目的:
- 为了全面分类LSD1在先天性和适应性瘤免疫力中的作用.
- 总结LSD1介导的瘤免疫和免疫逃生机制.
- 审查LSD1抑制剂在癌症免疫治疗中的地位.
主要方法:
- 在癌症和免疫学中对LSD1研究的文献综述.
- 分析LSD1影响免疫反应的机制.
- 关于用于免疫治疗的LSD1抑制剂的当前研究摘要.
主要成果:
- 较高的LSD1水平通过调节免疫检查点和细胞功能,对瘤免疫力产生负面影响.
- 抑制LSD1可以增强抗瘤免疫力,抑制瘤生长,提高免疫疗法的疗效.
- LSD1与瘤免疫逃生机制有关.
结论:
- LSD1是瘤免疫微环境的重要调节者.
- 针对LSD1提供了一个有希望的策略,以增强癌症免疫疗法.
- 进一步开发LSD1抑制剂作为组合治疗药物是有必要的.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
相关概念视频
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cell-mediated Immune Responses
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Tumor Immunotherapy
The Tumor Microenvironment
The Intrinsic Apoptotic Pathway
